The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma
Liu, Y., Lv, B., He, Z., Zhou, Y., Han, C., Shi, G., Gao, R., Wang, C., Yang, L., Song, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041610 · Cited by 40
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
Self-citationRegulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
ERM proteins and merlin: integrators at the cell cortex
Bretscher, A., Edwards, K., & Fehon, R. G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm882 · Cited by 1,306
Translational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294
Organizing the cell cortex: the role of ERM proteins
Fehon, R. G., McClatchey, A. I., & Bretscher, A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2866 · Cited by 1,044
Regulation of osteoblast differentiation by transcription factors
Komori, T. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20958 · Cited by 1,023
Notch signalling in solid tumours: a little bit of everything but not all the time
Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3035 · Cited by 824
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24320 · Cited by 791
Self-citationRecurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.031 · Cited by 717
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S. M., & Helman, L. J. (2004) · Nature Medicine · doi:10.1038/nm982 · Cited by 705
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers, P. A., Heller, G., Healey, J., Huvos, A., Lane, J., Marcove, R., Applewhite, A., Vlamis, V, & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 678
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Trends in childhood cancer incidence in the U.S. (1992–2004)
Linabery, A. M., & Ross, J. A. (2008) · Cancer · doi:10.1002/cncr.23169 · Cited by 643
Hilton, M. J., Tu, X., Wu, X., Bai, S., Zhao, H., Kobayashi, T., Kronenberg, H. M., Teitelbaum, S. L., Ross, F. P., Kopan, R., et al. (2008) · Nature Medicine · doi:10.1038/nm1716 · Cited by 604
Bacci, G., Longhi, A., Versari, M., Mercuri, M., Briccoli, A., & Picci, P. (2006) · Cancer · doi:10.1002/cncr.21724 · Cited by 569
Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., Hook, J. M., Arndt, C., van den Berg, H., Brennan, B., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30214-5 · Cited by 551
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Dorfman, H. D., & Czerniak, B. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v · Cited by 496
Recent insights into the role of Notch signaling in tumorigenesis
Leong, K. G., & Karsan, A. (2006) · Blood · doi:10.1182/blood-2005-08-3329 · Cited by 493
Mai, P. L., Best, A. F., Peters, J. A., DeCastro, R. M., Khincha, P. P., Loud, J. T., Bremer, R. C., Rosenberg, P. S., & Savage, S. A. (2016) · Cancer · doi:10.1002/cncr.30248 · Cited by 486
Self-citationCancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481
Osteogenic sarcoma. A study of six hundred cases.
Dahlin, D. C., & Coventry, M. B. (1967) · PubMed · Cited by 475
Osteogenic Sarcoma: A STUDY OF SIX HUNDRED CASES
DAHLIN, D. C., & COVENTRY, M. B. (1967) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-196749010-00008 · Cited by 451
Excess of rare cancers in Werner syndrome (adult progeria).
Goto, M., Miller, R. W., Ishikawa, Y., & Sugano, H. (1996) · PubMed · Cited by 442
Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0734 · Cited by 422
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., Ayala, A. G., Harris, M. B., Helman, L. J., Grier, H. E., & Link, M. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.165 · Cited by 395
Holdaway, I. M., & Rajasoorya, C. (1999) · Pituitary · doi:10.1023/a:1009965803750 · Cited by 394
Alterations of the Notch pathway in lung cancer
Westhoff, B., Colaluca, I. N., D'Ario, G., Donzelli, M., Tosoni, D., Volorio, S., Pelosi, G., Spaggiari, L., Mazzarol, G., Viale, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907781106 · Cited by 387
Osteosarcoma: Anatomic and Histologic Variants
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6kqhld9lv2kenn · Cited by 386
Dog models of naturally occurring cancer
Rowell, J. L., McCarthy, D. O., & Alvarez, C. E. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.004 · Cited by 384
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
Denny, S. K., Yang, D., Chuang, C.-H., Brady, J. J., Lim, J. S., Grüner, B. M., Chiou, S.-H., Schep, A. N., Baral, J., Hamard, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.052 · Cited by 368
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6k-qhld-9lv2-kenn · Cited by 367
MARCOVE, R. C., MIKÉ, V., HAJEK, J. V., LEVIN, A. G., & HUTTER, R. V. P. (1970) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-197052030-00001 · Cited by 361
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Kovac, M., Blattmann, C., Ribi, S., Smida, J., Mueller, N. S., Engert, F., Castro-Giner, F., Weischenfeldt, J., Kovacova, M., Krieg, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9940 · Cited by 353
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Tinat, J., Bougeard, G., Baert-Desurmont, S., Vasseur, S., Martin, C., Bouvignies, E., Caron, O., Bressac-de Paillerets, B., Berthet, P., Dugast, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7967 · Cited by 348
Sensitivity and predictive value of criteria for p53 germline mutation screening
CHOMPRET, A., ABEL, A., STOPPA-LYONNET, D., BRUGIÈRES, L., PAGÈS, S., FEUNTEUN, J., & BONAÏTI-PELLIÉ, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.43 · Cited by 341
Grignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 340
Sato, N., Funayama, N., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.1.131 · Cited by 337
Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu526 · Cited by 333
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
Contardi, E., Palmisano, G. L., Tazzari, P. L., Martelli, A. M., Falà, F., Fabbi, M., Kato, T., Lucarelli, E., Donati, D., Polito, L., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21155 · Cited by 324
Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients
Wang, L. L., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Lev, D., Rogers, M., & Plon, S. E. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010722)102:1<11::aid-ajmg1413>3.0.co;2-a · Cited by 322
Notch Signaling and the Skeleton
Zanotti, S., & Canalis, E. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1002 · Cited by 321
Vlachos, A., Rosenberg, P. S., Atsidaftos, E., Alter, B. P., & Lipton, J. M. (2012) · Blood · doi:10.1182/blood-2011-08-375972 · Cited by 309
Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beaughamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262001 · Cited by 307
Duchman, K. R., Gao, Y., & Miller, B. J. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.05.001 · Cited by 305
Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna, C., Khan, J. I., Nguyen, P., Prehn, J., Caylor, J., Yeung, C. L., Trepel, J. B., Meltzer, P. S., & Helman, L. J. (2001) · PubMed · Cited by 282
Molecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273
Mita, M. M., Mita, A. C., Chu, Q. S., Rowinsky, E. K., Fetterly, G. J., Goldston, M., Patnaik, A., Mathews, L., Ricart, A. D., Mays, T., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0345 · Cited by 273
Chawla, S. P., Staddon, A. P., Baker, L. H., Schuetze, S. M., Tolcher, A. W., D'Amato, G. Z., Blay, J.-Y., Mita, M. M., Sankhala, K. K., Berk, L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6329 · Cited by 246
Host related risk factors for canine osteosarcoma
Ru, G., Terracini, B., & Glickman, L. T. (1998) · The Veterinary Journal · doi:10.1016/s1090-0233(98)80059-2 · Cited by 243
Moriarity, B. S., Otto, G. M., Rahrmann, E. P., Rathe, S. K., Wolf, N. K., Weg, M. T., Manlove, L. A., LaRue, R. S., Temiz, N. A., Molyneux, S. D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3293 · Cited by 240
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
Janeway, K. A., & Grier, H. E. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70062-0 · Cited by 234
Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma
Kleinerman, R. A., Tucker, M. A., Abramson, D. H., Seddon, J. M., Tarone, R. E., & Fraumeni, J. F. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk002 · Cited by 234
The ribosomal basis of diamond-blackfan anemia: mutation and database update
Boria, I., Garelli, E., Gazda, H. T., Aspesi, A., Quarello, P., Pavesi, E., Ferrante, D., Meerpohl, J. J., Kartal, M., Da Costa, L., et al. (2010) · Human Mutation · doi:10.1002/humu.21383 · Cited by 233
The mutation spectrum in RECQL4 diseases
Siitonen, H. A., Sotkasiira, J., Biervliet, M., Benmansour, A., Capri, Y., Cormier-Daire, V., Crandall, B., Hannula-Jouppi, K., Hennekam, R., Herzog, D., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.154 · Cited by 231
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Ballinger, M. L., Goode, D. L., Ray-Coquard, I., James, P. A., Mitchell, G., Niedermayr, E., Puri, A., Schiffman, J. D., Dite, G. S., Cipponi, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30147-4 · Cited by 213
Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006767007547 · Cited by 207
Genome-wide association study identifies two susceptibility loci for osteosarcoma
Savage, S. A., Mirabello, L., Wang, Z., Gastier-Foster, J. M., Gorlick, R., Khanna, C., Flanagan, A. M., Tirabosco, R., Andrulis, I. L., Wunder, J. S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2645 · Cited by 202
Self-citationGermline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
McIntyre, J. F., Smith-Sorensen, B., Friend, S. H., Kassell, J., Borresen, A. L., Yan, Y. X., Russo, C., Sato, J., Barbier, N., & Miser, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.925 · Cited by 200
The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells
Elliott, B. E., Meens, J. A., SenGupta, S. K., Louvard, D., & Arpin, M. (2005) · Breast Cancer Research · doi:10.1186/bcr1006 · Cited by 198
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Le Vu, B., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<370::aid-ijc11>3.0.co;2-c · Cited by 193
Alterations of thep53, Rb andMDM2 genes in osteosarcoms
Miller, C. W., Aslo, A., Won, A., Tan, M., Lampkin, B., & Koefflar, H. P. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213553 · Cited by 190
Petrilli, A. S., de Camargo, B., Filho, V. O., Bruniera, P., Brunetto, A. L., Jesus-Garcia, R., Camargo, O. P., Pena, W., Péricles, P., Davi, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.5352 · Cited by 188
Pediatric and Adolescent Osteosarcoma
(2010) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9 · Cited by 183
Hoang, B. H., Kubo, T., Healey, J. H., Sowers, R., Mazza, B., Yang, R., Huvos, A. G., Meyers, P. A., & Gorlick, R. (2004) · International Journal of Cancer · doi:10.1002/ijc.11677 · Cited by 178
Notch signaling contributes to the pathogenesis of human osteosarcomas
Engin, F., Bertin, T., Ma, O., Jiang, M. M., Wang, L., Sutton, R. E., Donehower, L. A., & Lee, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp057 · Cited by 168
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Cohen-Solal, K. A., Boregowda, R. K., & Lasfar, A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0404-3 · Cited by 166
Huang, G., Nishimoto, K., Zhou, Z., Hughes, D., & Kleinerman, E. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1460 · Cited by 165
Bone cancer incidence by morphological subtype: a global assessment
Valery, P. C., Laversanne, M., & Bray, F. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0607-3 · Cited by 164
Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
Tanaka, M., Setoguchi, T., Hirotsu, M., Gao, H., Sasaki, H., Matsunoshita, Y., & Komiya, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605060 · Cited by 163
Semenova, E. A., Kwon, M.-C., Monkhorst, K., Song, J.-Y., Bhaskaran, R., Krijgsman, O., Kuilman, T., Peters, D., Buikhuisen, W. A., Smit, E. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.020 · Cited by 159
Germline TP53 Variants and Susceptibility to Osteosarcoma
Mirabello, L., Yeager, M., Mai, P. L., Gastier-Foster, J. M., Gorlick, R., Khanna, C., Patiño-Garcia, A., Sierrasesúmaga, L., Lecanda, F., Andrulis, I. L., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv101 · Cited by 155
Self-citationStature and malignant tumors of bone in childhood and adolescence
Fraumeni, J. F. (1967) · Cancer · Cited by 150
Notch signaling in developmental and tumor angiogenesis
Kofler, N. M., Shawber, C. J., Kangsamaksin, T., Reed, H. O., Galatioto, J., & Kitajewski, J. (2011) · Genes & Cancer · doi:10.1177/1947601911423030 · Cited by 142
Sadiković, B., Yoshimoto, M., Chilton‐MacNeill, S., Thorner, P. S., Squire, J. A., & Zieleńska, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp117 · Cited by 141
Cause-Specific Mortality in Long-Term Survivors of Retinoblastoma
Yu, C., Tucker, M. A., Abramson, D. H., Furukawa, K., Seddon, J. M., Stovall, M. A., Fraumeni, J. F., & Kleinerman, R. A. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp046 · Cited by 141
Notch Activation as a Driver of Osteogenic Sarcoma
Tao, J., Jiang, M., Jiang, L., Salvo, J. S., Zeng, H., Dawson, B., Bertin, T., Rao, P. H., Chen, R., Donehower, L. A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.023 · Cited by 137
Wong, J. R., Morton, L. M., Tucker, M. A., Abramson, D. H., Seddon, J. M., Sampson, J. N., & Kleinerman, R. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.7844 · Cited by 136
Stature of young people with malignant bone tumors
Cotterill, S. J., Wright, C. M., Pearce, M. S., & Craft, A. W. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10437 · Cited by 129
Tideman, H. (1995) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(05)80498-9 · Cited by 122
Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison
Marko, T. A., Diessner, B. J., & Spector, L. G. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25963 · Cited by 119
Paoloni, M. C., Tandle, A. T., Mazcko, C. N., Hanna, E., Kachala, S. S., LeBlanc, A. K., Newman, S. J., Vail, D. M., Henry, C. J., Thamm, D. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004972 · Cited by 118
Ma, Y., Ren, Y., Han, E. Q., Li, H., Chen, D., Jacobs, J. J., Gitelis, S., O’Keefe, R. J., Konttinen, Y. T., Yin, G., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.118 · Cited by 117
O’Neill, K. A., Murphy, M. F., Bunch, K. J., Puumala, S. E., Carozza, S. E., Chow, E. J., Mueller, B. A., McLaughlin, C. C., Reynolds, P., Vincent, T. J., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu265 · Cited by 117
Height at diagnosis and birth-weight as risk factors for osteosarcoma
Mirabello, L., Pfeiffer, R., Murphy, G., Daw, N. C., Patiño-Garcia, A., Troisi, R. J., Hoover, R. N., Douglass, C., Schüz, J., Craft, A. W., et al. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9763-2 · Cited by 116
Self-citationMirabello, L. J., Macari, E. R., Jessop, L., Ellis, S. R., Myers, T., Giri, N., Taylor, A. M., McGrath, K. E., Humphries, J. M., Ballew, B. J., et al. (2014) · Blood · doi:10.1182/blood-2013-11-540278 · Cited by 113
Self-citationCopy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors
Freeman, S. S., Allen, S. W., Ganti, R., Wu, J., Ma, J., Su, X., Neale, G. A. M., Dome, J. S., Daw, N. C., & Khoury, J. D. (2008) · Cancer · doi:10.1002/cncr.23782 · Cited by 111
Scranton, P. E., DeCicco, F., Totten, R. S., & Yunis, E. J. (1975) · Cancer · doi:10.1002/cncr.2820360936 · Cited by 111
Weng, W., Åhlén, J., Åström, K., Lui, W., & Larsson, C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0548 · Cited by 111
Mirabello, L. J., Koster, R., Moriarity, B. S., Spector, L. G., Meltzer, P. S., Gary, J. M., Machiela, M. J., Pankratz, N., Panagiotou, O. A., Largaespada, D. A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0125 · Cited by 109
Self-citationCao, Y., Zhou, Z., Crombrugghe, B. D., Nakashima, K., Guan, H., Duan, X., Jia, S.-F., & Kleinerman, E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2128 · Cited by 109
Epidemiology of osteosarcoma and Ewing's sarcoma in childhood
Buckley, J. D., Pendergrass, T. W., Buckley, C. M., Pritchard, D. J., Nesbit, M. E., Provisor, A. J., & Robison, L. L. (1998) · Cancer · Cited by 103
Ozaki, T., Wu, D., Sugimoto, H., Nagase, H., & Nakagawara, A. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.127 · Cited by 100
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer
Elzagheid, A. I., Korkeila, E. A., Bendardaf, R., Buhmeida, A. S., Heikkilä, S., Vaheri, A. I., Syrjänen, K. J., Pyrhönen, S. O., & Carpén, O. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.04.020 · Cited by 100
Lorenz, S., Barøy, T., Sun, J., Nome, T., Vodák, D., Bryne, J. C., Håkelien, A.-M., Fernandez‐Cuesta, L., Möhlendick, B., Rieder, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6567 · Cited by 100
Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic
Cai, Y., Cai, T., & Chen, Y. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24708 · Cited by 99
Height as a Risk Factor for Osteosarcoma
Longhi, A., Pasini, A., Cicognani, A., Baronio, F., Pellacani, A. U. E., Baldini, N., & Bacci, G. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000169251.57611.8e · Cited by 92
At-Risk Populations for Osteosarcoma: The Syndromes and Beyond
Calvert, G. T., Randall, R. L., Jones, K. B., Cannon-Albright, L., Lessnick, S., & Schiffman, J. D. (2012) · Sarcoma · doi:10.1155/2012/152382 · Cited by 90
Growth and development and other risk factors for osteosarcoma in children and young adults
Gelberg, K. H., Fitzgerald, E., Hwang, S. E., & Dubrow, R. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.272 · Cited by 89
Common mechanisms of osteosarcoma and paget's disease
Hansen, M. F., Nellissery, M. J., & Bhatia, P. (1999) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650140209 · Cited by 86
mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review)
Hu, K., Dai, H.-B., & Qiu, Z.-L. (2016) · Oncology Reports · doi:10.3892/or.2016.4922 · Cited by 82
Mu, X., Isaac, C. E., Greco, N., Huard, J., & Weiss, K. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00143 · Cited by 81
Oncology of infancy and childhood
Orkin, S. H. (2009) · Elsevier eBooks · Cited by 80
Savage, S. A., Woodson, K. G., Walk, E. L., Modi, W. S., Liao, J. S., Douglass, C. W., Hoover, R. N., Chanock, S. J., & The National Osteosarcoma Etiology Study Group (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0214 · Cited by 80
Self-citationZhou, Q., Deng, Z., Zhu, Y., Long, H., Zhang, S., & Zhao, J. (2009) · Medical Oncology · doi:10.1007/s12032-009-9365-y · Cited by 77
Osteosarcoma in Preadolescent Patients
Rytting, M., Pearson, P., Raymond, A. K., Ayala, A. G., Murray, J. A., Yasko, A. W., Johnson, M., & Jaffe, N. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200004000-00007 · Cited by 75
A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma
the National Osteosarcoma Etiology Study Group, Mirabello, L. J., Yu, K. F., Berndt, S. I., Burdett, L. A., Wang, Z., Chowdhury, S., Teshome, K., Uzoka, A., Hutchinson, A. A., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-209 · Cited by 75
Self-citationKöbel, M., Gradhand, E., Zeng, K., Schmitt, W., Kriese, K., Lantzsch, T., Wolters, M., Dittmer, J., Strauß, H. G., Thomssen, C., et al. (2006) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000185410.39050.ac · Cited by 74
Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis
Yu, X., Wu, T. Y., Xiang, Y., Wei-ping, R. E. N., Zhou, Z. B., Sun, Y., & Zhang, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1019-1 · Cited by 73
A CASE-CONTROL STUDY OF OSTEOSARCOMA IN YOUNG PERSONS
Operskalski, E. A., Preston‐Martin, S., Henderson, B. E., & Visscher, B. R. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114643 · Cited by 72
The pharmacogenomics of osteosarcoma
Serra, M., & Hattinger, C. M. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.45 · Cited by 71
Choy, E., Hornicek, F. J., MacConaill, L. E., Harmon, D. C., Tariq, Z., Garraway, L. A., & Duan, Z. (2011) · Cancer · doi:10.1002/cncr.26617 · Cited by 70
Lohmann, D. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_21 · Cited by 69
Age-Period-Cohort Analysis of Primary Bone Cancer Incidence Rates in the United States (1976–2005)
Anfinsen, K. P., Devesa, S. S., Bray, F., Troisi, R. J., Jónasdóttir, T. J., Bruland, Ø. S., & Grotmol, T. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0136 · Cited by 65
Dineen, R., Stewart, P. M., & Sherlock, M. (2016) · QJM · doi:10.1093/qjmed/hcw004 · Cited by 64
Toffoli, G., Biason, P., Russo, A. G., Mattia, E. D., Cecchin, E., Hattinger, C. M., Pasello, M., Alberghini, M., Ferrari, C., Scotlandi, K., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2249 · Cited by 61
Vásquez, L., Tarrillo, F., Oscanoa, M., Maza, I., Gerónimo, J., Paredes, G., Silva, J. M., & Sialer, L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00022 · Cited by 61
The role of pharmacogenetics in the treatment of osteosarcoma
Vos, H. I., Coenen, M. J. H., Guchelaar, H., & Loo, D. M. W. M. T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.022 · Cited by 61
Atypical Osteosarcomas in Werner Syndrome (Adult Progeria)
Ishikawa, Y., Miller, R. W., Machinami, R., Sugano, H., & Goto, M. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00924.x · Cited by 60
Cosimo, S. D., Sathyanarayanan, S., Bendell, J. C., Cervantes, A. M. R., Stein, M. N., Braña, I., Roda, D., Haines, B. B., Zhang, T., Winter, C. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0940 · Cited by 60
Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma
Liu, Y., He, Z., Feng, D., Shi, G., Gao, R., Wu, X., Song, W., & Yuan, W. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1269 · Cited by 60
Lin, C. H., Guo, Y., Ghaffar, S., McQueen, P., Pourmorady, J. S., Christ, A. B., Rooney, K., Ji, T., Eskander, R. H., Zi, X., et al. (2013) · Sarcoma · doi:10.1155/2013/147541 · Cited by 57
Perinatal factors, growth and development, and osteosarcoma risk
the National Osteosarcoma Etiology Group, Troisi, R. J., Masters, M. N., JOSHIPURA, K. J., Douglass, C. W., Cole, B. F., & Hoover, R. N. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603474 · Cited by 55
Role of Ezrin in Osteosarcoma Metastasis
Ren, L., & Khanna, C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_10 · Cited by 55
Ruza, E., Sotillo, E., maga, L. S. U., Azcona, C., & Patiño‐García, A. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200310000-00007 · Cited by 54
Ali, M. A. M. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0208-1 · Cited by 53
Bishop, M. W., Chang, Y., Krailo, M. D., Meyers, P. A., Provisor, A. J., Schwartz, C. L., Marina, N. M., Teot, L. A., Gebhardt, M. C., Gorlick, R., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26034 · Cited by 52
Recent advances in targeted therapy for Ewing sarcoma
Pishas, K. I., & Lessnick, S. L. (2016) · F1000Research · doi:10.12688/f1000research.8631.1 · Cited by 52
Understanding the Role of Notch in Osteosarcoma
McManus, M. M., Weiss, K. R., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_4 · Cited by 51
Telomere length and variation in telomere biology genes in individuals with osteosarcoma.
Mirabello, L., Richards, E. G., Duong, L. M., Yu, K. F., Wang, Z., Cawthon, R., Berndt, S. I., Burdett, L. A., Chowdhury, S., Teshome, K., et al. (2011) · PubMed · Cited by 50
Self-citationGerm‐line genetic variation of TP53 in osteosarcoma
Savage, S. A., Burdett, L. A., Troisi, R. J., Douglass, C. W., Hoover, R. N., & Chanock, S. J. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21077 · Cited by 50
Self-citationThe anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models
Zhu, Y., Zhou, X., Zhu, L., Yao, C., Fang, J., Zhou, F., Deng, X., & Zhang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10389 · Cited by 49
Berner, K., Hall, K. S., Monge, O. R., Weedon‐Fekjær, H., Zaikova, O., & Bruland, Ø. S. (2015) · Sarcoma · doi:10.1155/2015/516843 · Cited by 48
Wnt10b activates the wnt, notch, and NFκB pathways in u2os osteosarcoma cells
Mödder, U. I., Oursler, M. J., Khosla, S., & Monroe, D. G. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23048 · Cited by 47
Gvozdenovic, A., Boro, A., Meier, D., Bode‐Lesniewska, B., Born, W., Muff, R., & Fuchs, B. (2016) · Oncotarget · doi:10.18632/oncotarget.10461 · Cited by 45
Glutathione S-transferase polymorphisms in osteosarcoma patients
Salinas-Souza, C., Petrilli, A. S., & de Toledo, S. R. C. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833caa45 · Cited by 44
Dailey, D. D., Anfinsen, K. P., Pfaff, L. E., Ehrhart, E. J., Charles, J. B., Bønsdorff, T. B., Thamm, D. H., Powers, B. E., Jónasdóttir, T. J., & Duval, D. L. (2013) · BMC Veterinary Research · doi:10.1186/1746-6148-9-130 · Cited by 44
Fas Expression in Lung Metastasis From Osteosarcoma Patients
Gordon, N. B., Arndt, C. A. S., Hawkins, D. S., Doherty, D. K., Inwards, C. Y., Munsell, M. F., Stewart, J., Koshkina, N. V., & Kleinerman, E. S. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000188112.42576.df · Cited by 43
Patiño‐García, A., Sotillo, E., MODESTO, C., & SIERRASESÚMAGA, L. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.789 · Cited by 41
Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma
Yang, J., Zhao, L., Tian, W., Liao, Z., Zheng, H., Wang, G., & Chen, K. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-56 · Cited by 40
Wang, W., Wang, J., Song, H., Liu, J., Song, B., & Cao, X. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0264 · Cited by 39
Association between TGFBR1*6A and osteosarcoma: A Chinese case-control study
Hu, Y.-S., Pan, Y., Li, W., Zhang, Y., Li, J., & Ma, B. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-169 · Cited by 38
Exploratory Analysis of Fas Gene Polymorphisms in Pediatric Osteosarcoma Patients
Koshkina, N. V., Kleinerman, E. S., Li, G., Zhao, C., Wei, Q., & Sturgis, E. M. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181581506 · Cited by 35
Effect of Chemotherapy on Growth in the Skeletally Immature Individual
Glasser, D. B., Duane, K., Lane, J. M., Healey, J. H., & Caparros, B. (1991) · Springer eBooks · doi:10.1007/978-3-642-75879-9_72 · Cited by 35
Relationship between height at diagnosis and bone tumours in young people: a meta-analysis
Arora, R. S., Kontopantelis, E., Alston, R. D., Eden, T. O. B., Geraci, M., & Birch, J. M. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9740-9 · Cited by 34
Metabolic and endocrine alterations in osteosarcoma patients
Goodman, M. A., McMaster, J. H., DRASH, A. L., Diamond, P. E., Kappakas, G. S., & Scranton, P. E. (1978) · Cancer · Cited by 34
The Effect of Chemotherapy on Growth in the Skeletally Immature Individual
Glasser, D. B., Duane, K., Lane, J. M., Healey, J. H., & Caparros, B. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199101000-00013 · Cited by 34
Kolb, E. A., Gorlick, R. G., Keir, S. T., Maris, J. M., Lock, R. B., Carol, H., Kurmasheva, R. T., Reynolds, C. P., Kang, M. H., Wu, J., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23290 · Cited by 32
Kumar, R. M. R., Arlt, M., Kuzmanov, A., Born, W., & Fuchs, B. (2015) · Europe PMC (PubMed Central) · doi:10.5167/uzh-117024 · Cited by 32
Current Advances in Osteosarcoma
Kleinerman, E. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7 · Cited by 32
Receptor Tyrosine Kinases in Osteosarcoma: Not Just the Usual Suspects
Rettew, A. N., Getty, P. J., & Greenfield, E. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_3 · Cited by 31
High Birth Weight Increases the Risk for Bone Tumor: A Systematic Review and Meta-Analysis
Chen, S., Yang, L., Pu, F., Lin, H., Wang, B., Liu, J., & Shao, Z. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120911178 · Cited by 31
Height at diagnosis of malignancies.
Pui, C., Dodge, R. K., George, S. L., & Green, A. A. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.5.495 · Cited by 31
Wang, Z., Wen, P., Luo, X., Fang, X., Wang, Q., Ma, F., & Lv, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1475-7 · Cited by 31
Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population
Zhi, L., Ma, W., Zhang, H., Zeng, S., & Chen, B. (2013) · Tumor Biology · doi:10.1007/s13277-013-1425-4 · Cited by 31
Bridging the Gap Between Experimental Animals and Humans in Osteosarcoma
Withrow, S. J., & Khanna, C. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_24 · Cited by 27
Musselman, J. R. B., Bergemann, T. L., Ross, J. A., Sklar, C. A., Silverstein, K. A. T., Langer, E. K., Savage, S. A., Nagarajan, R., Krailo, M., Malkin, D. M., et al. (2012) · PubMed · Cited by 27
Self-citationRole of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma
Hattinger, C. M., & Serra, M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1060220 · Cited by 26
Huang, G., Nishimoto, K., Yang, Y., & Kleinerman, E. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_11 · Cited by 26
Jiang, C., Chen, H., Shao, L., & Dong, Y. (2014) · Medical Oncology · doi:10.1007/s12032-014-0050-4 · Cited by 25
Rapamycin inhibits tumor growth of human osteosarcomas.
Zhao, S., Lu, N.-J., Chai, Y., & Yu, X. (2015) · PubMed · Cited by 25
He, J., Wang, J., Wang, D., Dai, S., Yv, T., Chen, P., Ma, R., Diao, C., & Lv, G. (2014) · Endocrine · doi:10.1007/s12020-013-0050-8 · Cited by 24
Genetic variation at chromosome 8q24 in osteosarcoma cases and controls
Mirabello, L. J., Berndt, S. I., Seratti, G. F., Burdett, L. A., Yeager, M., Chowdhury, S., Teshome, K., Uzoka, A., Douglass, C. W., Hayes, R. B., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq117 · Cited by 23
Self-citation“Lassie,” “Toto,” and Fellow Pet Dogs: Poised to Lead the Way for Advances in Cancer Prevention
Knapp, D. W., Dhawan, D., & Ostrander, E. A. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e667 · Cited by 21
Osteosarcoma and acromegaly: A case report and review of the litereture
Lima, G. A. B., Gomes, E. M. S., Nunes, R. C., Neto, L. V., Sieiro, A. P. A. V., Brabo, E. P., & Gadelha, M. R. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349215 · Cited by 21
The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
Li, H., Min, D., Zhao, H., Wang, Z., Qi, W., Zheng, S., Tang, L., He, A., Sun, Y., Yao, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064513 · Cited by 20
Cao, Y., Jia, S.-F., Chakravarty, G., Crombrugghe, B. D., & Kleinerman, E. S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0090 · Cited by 19
Wu, L. C., Kleinerman, R. A., Curtis, R. E., Savage, S. A., & de González, A. B. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0810 · Cited by 17
Self-citationWu, Y., He, M., Zhao, J., & Wang, Z. (2013) · Medical Oncology · doi:10.1007/s12032-013-0826-y · Cited by 16
Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors
Naumov, V. A., Generozov, E. V., Solov’ev, Y. N., Джавадович, А. М., & Евгеньевич, К. Н. (2012) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-012-1847-9 · Cited by 16
Longitudinal Growth and Dental Development in Osteosarcoma Patients
Broström, L., Adamson, U. K. C., Filipsson, R., & Hall, K. E. (1980) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678008990870 · Cited by 16
Jiang, H., & Zeng, Z. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.119 · Cited by 15
Robl, B., Botter, S. M., Pellegrini, G., Neklyudova, O., & Fuchs, B. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0392-1 · Cited by 15
He, J., Wang, J., Wang, D., Dai, S., Yv, T., Chen, P., Ma, R., Diao, C., & Lv, G. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0260 · Cited by 14
Longitudinal Growth Following Treatment for Osteosarcoma
Cool, P., Grimer, R. J., Carter, S. R., Tillman, R. M., & Davies, A. M. (1998) · Sarcoma · doi:10.1080/13577149878073 · Cited by 14
Lugowska, I. A., Mierzejewska, E., Lenarcik, M., Klepacka, T., Koch, I., Michalak, E., & Szamotulska, K. (2016) · Tumor Biology · doi:10.1007/s13277-016-5091-1 · Cited by 14
The prognostic value of elevated ezrin in patients with osteosarcoma
Lun, D., Hu, Y., Xu, Z., Xu, L., & Wang, B.-W. (2013) · Tumor Biology · doi:10.1007/s13277-013-1168-2 · Cited by 11
Janeway, K. A., Gorlick, R. G., & Bernstein, M. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00022-4 · Cited by 10
Current advances in osteosarcoma
Kleinerman, E. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-4843_7 · Cited by 9
Hormonal evaluation in patients with osteosarcoma
Vassilopoulou‐Sellin, R., Wallis, C. J. D., & Samaan, N. A. (1985) · Journal of Surgical Oncology · doi:10.1002/jso.2930280313 · Cited by 8
Cited by
Second near-infrared photothermal materials for combinational nanotheranostics
Xu, C., & Pu, K. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00664e · Cited by 941
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Corre, I., Verrecchia, F., Crenn, V., Redini, F., & Trichet, V. (2020) · Cells · doi:10.3390/cells9040976 · Cited by 474
Molecular Biology of Osteosarcoma
Czarnecka, A. M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., Grieb, P., & Rutkowski, P. (2020) · Cancers · doi:10.3390/cancers12082130 · Cited by 336
Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy
Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280
Metadata
- Authors
- Gianferante, D. M., Mirabello, L., & Savage, S. A.
- Venue
- Nature Reviews Endocrinology
- Published
- 2017-03-24
- Volume
- 13
- Issue
- 8
- Pages
- 480-491
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2600572285
- Cited by
- 477
- References
- 190
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.